These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37788615)

  • 1. Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States.
    Yang KH; Kepner W; Nijum A; Han BH; Palamar JJ
    J Addict Med; 2023 Sep-Oct 01; 17(5):592-597. PubMed ID: 37788615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA.
    Haug NA; Wadekar R; Barry R; Sottile J
    J Psychoactive Drugs; 2024; 56(3):412-421. PubMed ID: 37384948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.
    Wu LT; Ringwalt CL; Weiss RD; Blazer DG
    Drug Alcohol Depend; 2009 Sep; 104(1-2):156-66. PubMed ID: 19500920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):57-65. PubMed ID: 34983261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.
    Palamar JJ
    J Psychoactive Drugs; 2018; 50(1):88-93. PubMed ID: 28937933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L; Chandler C; Sanders G
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underreporting of ecstasy use among high school seniors in the US.
    Palamar JJ; Keyes K; Cleland CM
    Drug Alcohol Depend; 2016 Aug; 165():279-82. PubMed ID: 27296977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.
    Price O; Man N; Bruno R; Dietze P; Salom C; Lenton S; Grigg J; Gibbs D; Wilson T; Degenhardt L; Chan R; Thomas N; Peacock A
    Addiction; 2022 Jan; 117(1):182-194. PubMed ID: 34159666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction.
    Rigg KK; Sharp A
    Addict Behav; 2018 Apr; 79():159-165. PubMed ID: 29291506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple drug ingestion by ecstasy abusers in the United States.
    Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
    J Anal Toxicol; 2009 Apr; 33(3):143-7. PubMed ID: 19371462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs.
    Gaddis A; Lake S; Tupper K; Nosova E; Blommaert K; Wood E; DeBeck K
    Drug Alcohol Depend; 2018 Nov; 192():112-117. PubMed ID: 30245459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample.
    Jones G; Ricard JA; Hendricks P; Simonsson O
    J Psychopharmacol; 2022 Oct; 36(10):1129-1135. PubMed ID: 36189781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.
    Palamar JJ; Mauro PM; Han BH; Martins SS
    Drug Alcohol Depend; 2017 Dec; 181():20-24. PubMed ID: 29028555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study.
    Yacoubian GS
    J Drug Educ; 2003; 33(1):61-9. PubMed ID: 12773025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.
    Palamar JJ; Kamboukos D
    Subst Use Misuse; 2014 Nov; 49(13):1774-83. PubMed ID: 24955818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.
    Jones GM
    J Psychopharmacol; 2023 Jan; 37(1):61-69. PubMed ID: 36314881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.
    Palamar JJ; Acosta P; Ompad DC; Cleland CM
    Subst Use Misuse; 2017 Jan; 52(1):82-91. PubMed ID: 27661470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.
    Palamar JJ; Salomone A; Gerace E; Di Corcia D; Vincenti M; Cleland CM
    Int J Drug Policy; 2017 Oct; 48():91-98. PubMed ID: 28810159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.
    Wu LT; Parrott AC; Ringwalt CL; Yang C; Blazer DG
    Am J Addict; 2009; 18(6):452-61. PubMed ID: 19874166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.